GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » YoY EPS Growth

LTR Pharma (ASX:LTP) YoY EPS Growth : -42.86% (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. LTR Pharma's YoY EPS Growth for the quarter that ended in Jun. 2023 was -42.86%.

LTR Pharma's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was A$-0.01.

LTR Pharma YoY EPS Growth Historical Data

The historical data trend for LTR Pharma's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma YoY EPS Growth Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23
YoY EPS Growth
- - -42.86

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23
YoY EPS Growth - - -42.86

LTR Pharma YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

LTR Pharma's YoY EPS Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY EPS Growth (A: Jun. 2023 )
=(Earnings per Share (Diluted) (A: Jun. 2023 )-Earnings per Share (Diluted) (A: Jun. 2022 ))/ | Earnings per Share (Diluted) (A: Jun. 2022 ) |
=(-0.01--0.007)/ | -0.007 |
=-42.86 %

LTR Pharma's YoY EPS Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EPS Growth (Q: Jun. 2023 )
=(Earnings per Share (Diluted) (Q: Jun. 2023 )-Earnings per Share (Diluted) (Q: Jun. 2022 )) / | Earnings per Share (Diluted) (Q: Jun. 2022 ) |
=(-0.01--0.007)/ | -0.007 |
=-42.86 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of LTR Pharma's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

LTR Pharma (ASX:LTP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » YoY EPS Growth
Comparable Companies
Traded in Other Exchanges
N/A
Address
9A/204 Alice Street, Brisbane, QLD, AUS, 4000
Website
https://www.ltrpharma.com
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines